Showing results (31-40 of 83) with videos related to

Sort By:
Pageof 9
Expert Opinion on Investigational Drugs|April 8, 2017
Investigational drugs targeting fibroblast growth factor receptor in the treatment of non-small cell lung cancerErika Rijavec, Carlo Genova, Giulia Barletta, et al.
Oncology and Therapy|June 17, 2021
Emerging issues related to COVID-19 vaccination in patients with cancerKamal S Saini, Diogo Martins-Branco, Marco Tagliamento, et al.
Breast Cancer Research and Treatment|November 3, 2021
Safety of systemic hormone replacement therapy in breast cancer survivors: a systematic review and meta-analysisFrancesca Poggio, Lucia Del Mastro, Marco Bruzzone, et al.
Breast Cancer : Basic and Clinical Research|September 21, 2020
Burning Questions in the Oncofertility Counseling of Young Breast Cancer PatientsLuca Arecco, Marta Perachino, Alessandra Damassi, et al.
European Journal of Cancer (Oxford, England : 1990)|June 10, 2026
Efficacy of alectinib for ALK-positive NSCLC according to tumor burden and body mass index: A pooled analysis of the randomized phase III trials ALEX and J-ALEXMarco Tagliamento, Marco Bruzzone, Eva Blondeaux, et al.
European Journal of Cancer (Oxford, England : 1990)|February 9, 2023
Clinical outcomes by infusion timing of immune checkpoint inhibitors in patients with advanced non-small cell lung cancerAdrien Rousseau, Marco Tagliamento, Edouard Auclin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 1, 2026
Non-Small Cell Lung Cancer (NSCLC) in Vulnerable and Special Populations: Towards Personalized CareClaudia Parisi, Andrea De Giglio, Marco Banini, et al.
Frontiers in Immunology|February 23, 2024
CD34+DNAM-1brightCXCR4+ haemopoietic precursors circulate after chemotherapy, seed lung tissue and generate functional innate-like T cells and NK cellsCarola Perrone, Federica Bozzano, Maria Giovanna Dal Bello, et al.
Pageof 9